https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/conference-coverage

The Latest

Taking a Closer Look at Cancer Treatment Rates Among Elderly Adults Living With HIV Img

Taking a Closer Look at Cancer Treatment Rates Among Elderly Adults Living With HIV

Studies suggest that people who are HIV-positive are less likely to receive cancer treatment than those who are HIV-negative. Anne Rositch, Ph.D., discusses why this "HIV effect" might exist.

Bone Density Decreases More for Individuals Living With HIV in U.S. Study Img

Bone Density Decreases More for Individuals Living With HIV in U.S. Study

Bone mineral density (BMD) declined significantly more in antiretroviral-treated U.S. study participants with HIV than in age-similar HIV-negative adults over seven years of follow-up.

Fewer Renal or Bone Events With Atripla Than Stribild in Large Database Img

Fewer Renal or Bone Events With Atripla Than Stribild in Large Database

Renal adverse events and fractures proved rare among people taking tenofovir disoproxil fumarate (TDF) as part of a single-tablet regimen in a large U.S. database of insured patients.

Switch From TDF to TAF Tied to Better Bone Mineral Density and Bone Markers Img

Switch From TDF to TAF Tied to Better Bone Mineral Density and Bone Markers

Bone mineral density (BMD) improved in the 96 weeks after patients switched from a combination containing tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) as part of the single-tablet regimen elvitegravir/cobicistat/emtricitabine/TA...

HPV, HIV and Cervical Cancer: Leveraging Synergies to Save Women's Lives Img

HPV, HIV and Cervical Cancer: Leveraging Synergies to Save Women's Lives

The burden that HIV places on women, particularly adolescent girls and young women from low- and middle-income countries, is compounded by the global burden of human papillomavirus (HPV) infection and cervical cancer.

No Effect of Tenofovir on Infant Bone Mineral Content in African Study Img

No Effect of Tenofovir on Infant Bone Mineral Content in African Study

A report from the PROMISE study showed no adverse bone mineral effect, linked to maternal tenofovir disoproxil fumarate (TDF), in exposed infants.

Six-Week Ledipasvir/Sofosbuvir in HIV-Positive Patients With Acute HCV Img

Six-Week Ledipasvir/Sofosbuvir in HIV-Positive Patients With Acute HCV

Researchers investigated using the combined ledipasvir/sofosbuvir for only six weeks in a small group of HIV-positive people diagnosed with acute hepatitis C.

Neurological Problems Don't Affect Everyone Living With HIV (Video) Img

Neurological Problems Don't Affect Everyone Living With HIV (Video)

While neurocognitive problems may appear very early on in acute HIV infection, "there is a profound misconception that HIV will affect the brain in everyone," says Bruce J. Brew, M.D., F.R.A.C.P.

Large Study Looks at Risk Factors for Bone Problems in HIV Img

Large Study Looks at Risk Factors for Bone Problems in HIV

Further research bolsters findings that HIV-positive people are at increased risk for developing osteopenia and osteoporosis and, in rare cases, osteonecrosis.

Zoledronic Acid Maintains Bone Density in ART Users Img

Zoledronic Acid Maintains Bone Density in ART Users

A small clinical trial found that a single infusion of zoledronic acid prevented ART-induced bone loss for one year.